Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001956827-25-000010
Filing Date
2025-03-24
Accepted
2025-03-24 17:00:26
Documents
193
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 20-F abvx-20241231.htm   iXBRL 20-F 12070117
2 EX-1.1 abivax-20xfxex11bylaws6feb.htm EX-1.1 155555
3 EX-2.1 abivax-20xfxex21descriptio.htm EX-2.1 225050
4 EX-4.16 abivax-20xfxex416summaryof.htm EX-4.16 17203
5 EX-4.17 abivax-20xfxex417summaryof.htm EX-4.17 10150
6 EX-4.18 abivax-20xfxex418summaryof.htm EX-4.18 37729
7 EX-11.1 abivax-codeofmarketconduct.htm EX-11.1 139786
8 EX-12.1 abivax-20xfxexhibit121ceo3.htm EX-12.1 11548
9 EX-12.2 abivax-20xfxexhibit122cfo3.htm EX-12.2 9766
10 EX-13.1 abivax-20xfxexhibit131ceo3.htm EX-13.1 4462
11 EX-13.2 abivax-20xfxexhibit132cfo3.htm EX-13.2 4527
12 EX-15.1 a4abivaxfy24_consentforf3v.htm EX-15.1 11215
13 EX-97.1 abivax-20xfxex971incentive.htm EX-97.1 48227
19 abvx-20241231_g1.jpg GRAPHIC 119771
20 abvx-20241231_g10.jpg GRAPHIC 20064
21 abvx-20241231_g11.jpg GRAPHIC 11868
22 abvx-20241231_g12.jpg GRAPHIC 30043
23 abvx-20241231_g13.jpg GRAPHIC 36377
24 abvx-20241231_g14.jpg GRAPHIC 53298
25 abvx-20241231_g15.jpg GRAPHIC 112119
26 abvx-20241231_g16.jpg GRAPHIC 31813
27 abvx-20241231_g17.jpg GRAPHIC 30014
28 abvx-20241231_g18.jpg GRAPHIC 21724
29 abvx-20241231_g19.jpg GRAPHIC 31933
30 abvx-20241231_g2.jpg GRAPHIC 93856
31 abvx-20241231_g20.jpg GRAPHIC 124410
32 abvx-20241231_g21.jpg GRAPHIC 124014
33 abvx-20241231_g22.jpg GRAPHIC 164573
34 abvx-20241231_g23.jpg GRAPHIC 148606
35 abvx-20241231_g24.jpg GRAPHIC 20930
36 abvx-20241231_g3.jpg GRAPHIC 31561
37 abvx-20241231_g4.jpg GRAPHIC 22470
38 abvx-20241231_g5.jpg GRAPHIC 42642
39 abvx-20241231_g6.jpg GRAPHIC 36937
40 abvx-20241231_g7.jpg GRAPHIC 33341
41 abvx-20241231_g8.jpg GRAPHIC 24157
42 abvx-20241231_g9.jpg GRAPHIC 24849
43 image_0.jpg GRAPHIC 2000
44 image_0b.jpg GRAPHIC 9503
45 image_1.jpg GRAPHIC 4805
  Complete submission text file 0001956827-25-000010.txt   45704352

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abvx-20241231.xsd EX-101.SCH 197464
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abvx-20241231_cal.xml EX-101.CAL 129712
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abvx-20241231_def.xml EX-101.DEF 998436
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abvx-20241231_lab.xml EX-101.LAB 1316474
18 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abvx-20241231_pre.xml EX-101.PRE 1264056
196 EXTRACTED XBRL INSTANCE DOCUMENT abvx-20241231_htm.xml XML 9646532
Mailing Address 7 BD HAUSSMANN PARIS I0 75009
Business Address 7 BD HAUSSMANN PARIS I0 75009 01 53 83 09 63
Abivax S.A. (Filer) CIK: 0001956827 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-41842 | Film No.: 25764931
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)